Medical News Today, July 9 2008 The Strategic Program for Asthma Research has awarded UTMB professor Satish Srivastava a three-year, $750,000 grant to pursue an innovative approach to asthma therapy. Srivastava will use the award to examine the link between the enzyme aldose reductase and asthma-related lung inflammation. Previous research by Srivastava's group has shown that this enzyme is essential to inflammatory mechanisms in colon cancer, diabetic cardiovascular complications, autoimmune disease, sepsis and uveitis.